MEDP
Medpace Holdings, Inc.NASDAQHealthcare$498.34+1.81%ClosedMarket Cap: $14.14B
As of 2026-04-06
Valuation
P/E (TTM)
31.35
PEG
2.71
P/B
30.71
P/S
5.59
EV/EBITDA
25.18
DCF Value
$363.02
FCF Yield
5.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
30.1%
Operating Margin
21.1%
Net Margin
17.8%
ROE
118.8%
ROA
35.3%
ROIC
67.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $708.5M | 29.0% | $153.3M | $135.1M | $4.67 | — |
| FY 2025 | $2.53B | 30.1% | $534.9M | $451.1M | $15.28 | — |
| Q3 2025 | $659.9M | 29.8% | $141.8M | $111.1M | $3.87 | — |
| Q2 2025 | $603.3M | 29.8% | $126.3M | $90.3M | $3.10 | — |
| Q1 2025 | $558.6M | 31.9% | $113.5M | $114.6M | $3.67 | — |
| Q4 2024 | $536.6M | 33.2% | $125.4M | $117.0M | $3.67 | — |
| FY 2024 | $2.11B | 31.1% | $446.9M | $404.4M | $12.63 | — |
| Q3 2024 | $533.3M | 31.7% | $112.3M | $96.4M | $3.01 | — |
| Q2 2024 | $528.1M | 29.1% | $105.2M | $88.4M | $2.75 | — |
| Q1 2024 | $511.0M | 30.4% | $104.1M | $102.6M | $3.20 | — |
| Q4 2023 | $498.4M | 27.4% | $87.3M | $78.3M | $2.46 | — |
| FY 2023 | $1.89B | 27.8% | $336.8M | $282.8M | $8.88 | — |